NeurologyLive® Mind Moments®

140: Down Syndrome and Alzheimer’s: Clinical Trials, Equity, and Patient-Centered Progress


Listen Later

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.

In this episode, "Down Syndrome and Alzheimer’s: Clinical Trials, Equity, and Patient-Centered Progress," Elizabeth Head, PhD, professor in the department of Pathology and Laboratory Medicine at the University of California, Irvine, discussed the evolving intersection of Down syndrome and Alzheimer disease using updates from the Alzheimer Biomarker Consortium – Down Syndrome (ABC-DS). She detailed how outcome assessments have been refined to meet the unique cognitive profiles of individuals with Down syndrome and shared the progress in launching clinical trials that now include this historically excluded population. Head also addressed the challenges in distinguishing developmental delay from early dementia symptoms, the potential role of anti-amyloid therapies, and how non-pharmacological interventions like sleep apnea treatment may contribute to cognitive preservation. She emphasized the importance of equitable research participation, clinician education, and understanding patient priorities—like independence and respect—when supporting individuals with Down syndrome and their families.

Looking for more Alzheimer disease/dementia discussion? Check out the NeurologyLive® Alzheimer disease/dementia clinical focus page.

Episode Breakdown:
  • 1:00 – Overview of the ABC-DS initiative and the growing inclusion of Down syndrome in Alzheimer research
  • 2:00– Current state of clinical trials and progress in therapeutic development for this population
  • 3:30 – Evolution of outcome assessments tailored for individuals with Down syndrome
  • 5:40 – Challenges in distinguishing Down syndrome traits from signs of early dementia
  • 7:40 – Clinician educations needs and improving access to specialized care
  • 9:00 – Neurology News Minute
  • 11:00 – Eligibility and considerations for anti-amyloid therapies in Down syndrome
  • 13:35 – Research gaps, co-occurring conditions, and the importance of reaching underserved populations
  • 16:40 – Top priorities from patients and families: independence, inclusion, and respect in care settings

    The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:

    • GENERATION HD2 Trial of Huntington Agent Tominersen Amended to Include Only Higher Dose
    • FDA Grants Authorization to Epiminder’s Implantable Continuous EEG Monitor for Epilepsy Treatment
    • FDA Approves FcRn Blocker Nipocalimab for Broad Forms of Generalized Myasthenia Gravis

    • Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
      ...more
      View all episodesView all episodes
      Download on the App Store

      NeurologyLive® Mind Moments®By NeurologyLive

      • 4.6
      • 4.6
      • 4.6
      • 4.6
      • 4.6

      4.6

      10 ratings


      More shows like NeurologyLive® Mind Moments®

      View all
      The Clark Howard Podcast by Clark Howard

      The Clark Howard Podcast

      5,394 Listeners

      Neurology® Podcast by American Academy of Neurology

      Neurology® Podcast

      289 Listeners

      NEJM This Week by NEJM Group

      NEJM This Week

      320 Listeners

      Practical Neurology Podcast by BMJ Group

      Practical Neurology Podcast

      49 Listeners

      JAMA Neurology Author Interviews by JAMA Network

      JAMA Neurology Author Interviews

      13 Listeners

      BMJ Best Practice Podcast by BMJ Group

      BMJ Best Practice Podcast

      23 Listeners

      Neurology Today in 5 by American Academy of Neurology

      Neurology Today in 5

      22 Listeners

      Neurology Minute by American Academy of Neurology

      Neurology Minute

      131 Listeners

      Dateline NBC by NBC News

      Dateline NBC

      47,504 Listeners

      The Ezra Klein Show by New York Times Opinion

      The Ezra Klein Show

      15,495 Listeners

      Chanticleer by Australian Financial Review

      Chanticleer

      15 Listeners

      Movers and Shakers: a podcast about life with Parkinson's by Podot

      Movers and Shakers: a podcast about life with Parkinson's

      97 Listeners

      The Top Line by Fierce Life Sciences

      The Top Line

      12 Listeners

      Continuum Audio by American Academy of Neurology

      Continuum Audio

      79 Listeners

      The Economics Show by Financial Times

      The Economics Show

      123 Listeners